Reduce Tobacco Use in People Living With HIV in Switzerland
Recruiting · NCT06789692 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital, Basel, Switzerland
View the official record on ClinicalTrials.gov →Interventions studied
tobacco smoking substitution products
What this trial is about
The purpose of this trial is to test the effectiveness of offering a menu of different tobacco smoking substitutional products (e-cigarettes, nicotine pouches, nicotine patches in addition to usual of care) for smokers in the SHCS (Swiss HIV Cohort Study) in achieving self-reported 7-day tobacco cigarette abstinence at 6 months.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Signed informed consent for the data collection and participation in the SHCS (Cohort consent).
- Signed informed consent to be randomized to future interventions (Randomization consent).
- Age 18 years or older.
- Smoked one or more tobacco cigarettes per day (smoking status = yes) at the time of enrolment.
Exclusion criteria
- Currently using e-cigarettes or nicotine pouches or nicotine patches.
- Pregnant women.
Where it is running
7 locations listed.
- Cantonal Hospital Aarau - Aarau, Switzerland
- University Hospital Geneva - Geneva, Switzerland
- University Hospital Basel - Basel, Basel, Switzerland
- Inselspital Bern - Bern, Canton of Bern, Switzerland
- Cantonal Hospital St. Gallen - Sankt Gallen, Canton of St. Gallen, Switzerland
- University Hospital Lausanne - Lausanne, Canton of Vaud, Switzerland
- University Hospital Zurich - Zurich, Canton of Zurich, Switzerland